美国 · SEC FORM 4
OptimizeRx Corp
OPRX · Nasdaq · CIK 0001448431 · Healthcare · Health Information Services
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
21 同一窗口内观察到的 Form 4 交易行
0 sales · 21 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-03-14 · Lang James Paul.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,116,126
- 上期报告
- 1,008,836
- 日均成交量
- 193,597
- 回补天数
- 5.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-03-14 | Lang James Paul | 买入 (P) | Common Stock | 321,408 | USD 7.60 | USD 2,442,701 | SEC 申报 ↗ |
| 2024-12-12 | FEBBO WILLIAM J | 买入 (P) | Common Stock | 20,000 | USD 5.01 | USD 100,200 | SEC 申报 ↗ |
| 2022-08-26 | Odence-Ford Marion | 买入 (P) | Common Stock | 1,000 | USD 15.75 | USD 15,750 | SEC 申报 ↗ |
| 2022-08-22 | FEBBO WILLIAM J | 买入 (P) | Common Stock | 10,700 | USD 15.29 | USD 163,603 | SEC 申报 ↗ |
| 2022-08-19 | Lang James Paul | 买入 (P) | Common Stock | 6,000 | USD 16.45 | USD 98,700 | SEC 申报 ↗ |
| 2022-08-19 | FEBBO WILLIAM J | 买入 (P) | Common Stock | 5,400 | USD 16.18 | USD 87,372 | SEC 申报 ↗ |
| 2022-08-16 | Vos Ellen O'Connor | 买入 (P) | Common Stock | 500 | USD 15.91 | USD 7,955 | SEC 申报 ↗ |
| 2022-08-16 | Silvestro Stephen L | 买入 (P) | Common Stock | 3,200 | USD 15.66 | USD 50,112 | SEC 申报 ↗ |
| 2022-08-15 | Stelmakh Edward | 买入 (P) | Common Stock | 3,000 | USD 15.43 | USD 46,290 | SEC 申报 ↗ |
| 2020-08-07 | WASSON GREGORY D | 买入 (P) | Common Stock | 15,000 | USD 17.49 | USD 262,350 | SEC 申报 ↗ |
| 2020-03-31 | Vos Ellen O'Connor | 买入 (P) | Common Stock | 1,000 | USD 8.75 | USD 8,750 | SEC 申报 ↗ |
Form 4 申报证据
44 transaction lines in the latest 365-day window; 339 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | D'Silva Andrew J. | 代扣税 (F) | Common Stock | 414 | USD 8.39 | USD 3,473 | SEC 申报 ↗ |
| 2026-09-01 | D'Silva Andrew J. | 代扣税 (F) | Common Stock | 1,432 | USD 7.86 | USD 11,256 | SEC 申报 ↗ |
| 2026-08-21 | Stelmakh Edward | 代扣税 (F) | Common Stock | 1,381 | USD 7.71 | USD 10,648 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | D'Silva Andrew J. | 代扣税 (F) | Common Stock | 414 | USD 8.39 | USD 3,473 | SEC 申报 ↗ |
| 2026-09-01 | D'Silva Andrew J. | 代扣税 (F) | Common Stock | 1,432 | USD 7.86 | USD 11,256 | SEC 申报 ↗ |
| 2026-08-21 | Stelmakh Edward | 代扣税 (F) | Common Stock | 1,381 | USD 7.71 | USD 10,648 | SEC 申报 ↗ |
| 2026-08-21 | Silvestro Stephen L | 代扣税 (F) | Common Stock | 1,737 | USD 7.71 | USD 13,392 | SEC 申报 ↗ |
| 2026-08-21 | Odence-Ford Marion | 代扣税 (F) | Common Stock | 1,529 | USD 7.71 | USD 11,789 | SEC 申报 ↗ |
| 2026-08-21 | Merrell Brendan W. | 代扣税 (F) | Common Stock | 1,020 | USD 7.71 | USD 7,864 | SEC 申报 ↗ |
| 2026-08-21 | D'Silva Andrew J. | 代扣税 (F) | Common Stock | 1,243 | USD 7.71 | USD 9,584 | SEC 申报 ↗ |
| 2026-08-20 | Silvestro Stephen L | 奖励／授予 (A) | Common Stock | 79,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-20 | Odence-Ford Marion | 奖励／授予 (A) | Common Stock | 57,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-20 | Merrell Brendan W. | 奖励／授予 (A) | Common Stock | 57,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-20 | D'Silva Andrew J. | 奖励／授予 (A) | Common Stock | 57,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | WASSON GREGORY D | 奖励／授予 (A) | Common Stock | 34,517 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Vos Ellen O'Connor | 奖励／授予 (A) | Common Stock | 34,517 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Spangler Patrick D | 奖励／授予 (A) | Common Stock | 34,517 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Presti Mariyamma Varghese | 奖励／授予 (A) | Common Stock | 17,258 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | Lang James Paul | 奖励／授予 (A) | Common Stock | 34,517 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-09 | KLEMA CATHY | 奖励／授予 (A) | Common Stock | 34,517 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Silvestro Stephen L | 代扣税 (F) | Common Stock | 5,219 | USD 5.21 | USD 27,191 | SEC 申报 ↗ |
| 2026-05-15 | Greco Theresa | 代扣税 (F) | Common Stock | 1,793 | USD 5.21 | USD 9,342 | SEC 申报 ↗ |
| 2026-05-01 | Presti Mariyamma Varghese | 奖励／授予 (A) | Common Stock | 13,060 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Odence-Ford Marion | 期权行权／转换 (M) | Common Stock | 4,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-11 | Odence-Ford Marion | 代扣税 (F) | Common Stock | 1,386 | USD 9.23 | USD 12,793 | SEC 申报 ↗ |
| 2025-12-23 | Stelmakh Edward | 代扣税 (F) | Common Stock | 3,658 | USD 12.74 | USD 46,603 | SEC 申报 ↗ |
| 2025-12-23 | Silvestro Stephen L | 代扣税 (F) | Common Stock | 3,361 | USD 12.74 | USD 42,819 | SEC 申报 ↗ |
| 2025-12-23 | Silvestro Stephen L | 代扣税 (F) | Common Stock | 3,361 | USD 12.74 | USD 42,819 | SEC 申报 ↗ |
| 2025-12-23 | Odence-Ford Marion | 代扣税 (F) | Common Stock | 4,051 | USD 12.74 | USD 51,610 | SEC 申报 ↗ |
| 2025-12-23 | Greco Theresa | 代扣税 (F) | Common Stock | 1,420 | USD 12.74 | USD 18,091 | SEC 申报 ↗ |
| 2025-12-23 | Besch Doug | 代扣税 (F) | Common Stock | 4,079 | USD 12.74 | USD 51,966 | SEC 申报 ↗ |
| 2025-12-19 | Stelmakh Edward | 期权行权／转换 (M) | Common Stock | 5,237 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-19 | Stelmakh Edward | 代扣税 (F) | Common Stock | 1,388 | USD 13.51 | USD 18,752 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | OPRX |
| CIK | 0001448431 |
| 行业 | Healthcare |
| 细分行业 | Health Information Services Yahoo Finance |
| SEC SIC | 7389 Services-Business Services, NEC |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 339 transaction lines from 2020-01-03 to 2026-10-01 11 P purchase lines · 65 S sale lines · 263 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.